This paper is in the following e-collection/theme issue:

Innovations and Technology in Cancer Care (491) Web-based and Mobile Health Interventions (3802) Mobile Apps for Cancer Care and Cancer Prevention and Screening (249) Usability of Apps and User Perceptions of mHealth (1130) Formative Evaluation of Digital Health Interventions (2984) Telehealth and Telemonitoring (1963) Nutrition, Physical Activity, Healthy Lifestyle for Cancer Patients and Survivors (167) Prostate Cancer (44)

Published on in Vol 10 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/51061, first published .
A Smart Water Bottle and Companion App (HidrateSpark 3) to Improve Bladder-Filling Compliance in Patients With Prostate Cancer Receiving Radiotherapy: Nonrandomized Trial of Feasibility and Acceptability

A Smart Water Bottle and Companion App (HidrateSpark 3) to Improve Bladder-Filling Compliance in Patients With Prostate Cancer Receiving Radiotherapy: Nonrandomized Trial of Feasibility and Acceptability

A Smart Water Bottle and Companion App (HidrateSpark 3) to Improve Bladder-Filling Compliance in Patients With Prostate Cancer Receiving Radiotherapy: Nonrandomized Trial of Feasibility and Acceptability

Authors of this article:

William Jin1, 2 Author Orcid Image ;   Christopher Montoya1, 2 Author Orcid Image ;   Benjamin James Rich1, 2 Author Orcid Image ;   Crystal Seldon Taswell1, 2 Author Orcid Image ;   Miguel Noy2 Author Orcid Image ;   Deukwoo Kwon3, 4 Author Orcid Image ;   Benjamin Spieler2 Author Orcid Image ;   Brandon Mahal2 Author Orcid Image ;   Matthew Abramowitz2 Author Orcid Image ;   Raphael Yechieli2 Author Orcid Image ;   Alan Pollack2 Author Orcid Image ;   Alan Dal Pra2 Author Orcid Image
Article Authors Cited by (1) Tweetations (3) Metrics

Journals

  1. Gómez-Luque M, Rivero-Belenchón I, Congregado-Ruiz C, Escobar-Rodríguez G, Delgado-Granados F, Rivas-González J, Medina-López R. The Role of mHealth Applications in Uro-Oncology: A Systematic Review and Future Directions. Cancers 2025;17(16):2613 View